Johansen, O. E., Neubacher, D., von Eynatten, M., Patel, S., & Woerle, H. (2012). Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: A pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme. BioMed Central.
Chicago-стиль цитированияJohansen, Odd Erik, Dietmar Neubacher, Maximilian von Eynatten, Sanjay Patel, and Hans-Juergen Woerle. Cardiovascular Safety With Linagliptin in Patients With Type 2 Diabetes Mellitus: A Pre-specified, Prospective, and Adjudicated Meta-analysis of a Phase 3 Programme. BioMed Central, 2012.
MLA-цитированиеJohansen, Odd Erik, et al. Cardiovascular Safety With Linagliptin in Patients With Type 2 Diabetes Mellitus: A Pre-specified, Prospective, and Adjudicated Meta-analysis of a Phase 3 Programme. BioMed Central, 2012.